Cited by 247Nonmelanoma Skin Cancer StudiesPhotodynamic Therapy Research StudiesHead and Neck Cancer Studies

A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8–20 mm), with a 12-month follow-up

Szeimies, RM, Ibbotson, S, Murrell, DF, Rubel, D, Frambach, Y, De Berker, D, Dummer, R, Kerrouche, N +2 more·2008·Journal of the European Academy of Dermatology and Venereology

Abstract

OBJECTIVE: To compare the efficacy and cosmetic outcome (CO) of photodynamic therapy with topical methyl aminolevulinate (MAL-PDT) with simple excision surgery for superficial basal cell carcinoma (sBCC) over a 1-year period. METHODS: In this multicentre, randomised, controlled, open study, patients were treated at baseline either with MAL-PDT (two sessions, 7 days apart, repeated 3 months later if incomplete clinical response) or surgery (at baseline). Primary endpoints were clinical lesion response (CR) 3 months after last treatment and CO assessed by the investigator 12 months after last treatment. Secondary endpoints were CR at 12 months (i.e. recurrence) and CO assessed by the investigator at 3 and 6 months and by the patient at 3, 6 and 12 months. RESULTS: Overall, 196 patients were enrolled with 1.4 sBCC lesions on average per patient. Mean lesion count reduction at 3 months was 92.2% with MAL-PDT vs. 99.2% with surgery [per protocol (PP) population] confirming the non-inferiority hypothesis (95% confidence interval, -12.1, -1.9). A total of 92.2% lesions showed CR at 3 months with MAL-PDT vs. 99.2% with surgery (PP population). At 12 months, 9.3% lesions recurred with MAL-PDT and none with surgery. CO was statistically superior for MAL-PDT at all time points. At 12 months, 94.1% lesions treated with MAL-PDT had an excellent or good CO according to the investigator compared with 59.8% with surgery. This difference was confirmed with the patients' assessment. The proportion of excellent CO markedly improved with time with MAL-PDT unlike surgery. CONCLUSIONS: MAL-PDT offers a similarly high efficacy and a much better CO than simple excision surgery in the treatment of sBCC.

Integrity signals

Registry

Crossref · 10.1111/j.1468-3083.2008.02803.x

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several studies have shown that PDT results in superior cosmetic outcomes compared to surgical treatment.

    “Several studies have shown that PDT results in superior cosmetic outcomes compared to surgical treatment.”

    From Photodynamic Therapy for Non-Melanoma Skin Cancers (2016) · cites this paper as [42]

  • Compared to surgical excision, PDT appears to result in higher BCC recurrence rates.

    “Compared to surgical excision, PDT appears to result in higher BCC recurrence rates [42,47,51,52,54].”

    From Photodynamic Therapy for Non-Melanoma Skin Cancers (2016) · cites this paper as [42]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Szeimies, R., Ibbotson, S., Murrell, D., Rubel, D., Frambach, Y., De Berker, D., Dummer, R., Kerrouche, N., Villemagne, H., & on behalf of the Excilight Study Group
Affiliations
  • University Hospital Regensburg (DE)
  • Ninewells Hospital (GB)
  • Skin and Cancer Foundation (AU)
  • University of Lübeck (DE)
  • University Hospital Zurich (CH)
  • Galderma (France) (FR)
Corresponding author
Szeimies, RM
Venue
Journal of the European Academy of Dermatology and Venereology
Publisher
Wiley
Published
2008-10-10
Volume
22
Issue
11
Pages
1302-1311
ISSN
  • 0926-9959 (ISSN-L)
  • 1468-3083
OpenAlex
W2167106546
Cited by
247
References
28
Citations by year
2026: 6 · 2025: 12 · 2024: 8 · 2023: 11 · 2022: 12 · 2021: 15 · 2020: 13 · 2019: 19 · 2018: 25 · 2017: 19 · 2016: 17 · 2015: 19 · 2014: 13 · 2013: 16 · 2012: 9
FWCI
7.92
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the European Academy of Dermatology and Venereology (publishedVersion)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion)
  • University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Nonmelanoma Skin Cancer Studies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Photodynamic Therapy Research Studies
  • Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
Keywords
superficial basal cell carcinoma, methyl aminolevulinate, photodynamic therapy, surgical excision, cosmetic outcome, recurrence, treatment efficacy, non-inferiority
MeSH terms
Administration, Topical, Adult, Aged, Aged, 80 and over, Aminolevulinic Acid, Basal Cell Carcinoma, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Male, Middle Aged, Photochemotherapy, Skin Neoplasms, Treatment Outcome, Photosensitizing Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review